TORONTO -- (MARKET WIRE) -- October 25, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Anna Gluskin, the Company’s President & Chief Executive Officer, will be presenting at The C.E. Unterberg, Towbin Life Sciences Conference in New York City, October 30 - 31, 2006. Ms. Gluskin’s presentation is scheduled for 1 p.m. (EST) on Monday, October 30, 2006 at The Palace Hotel.
